Haruyo Ujike

Renal distribution of Vasohibin-1 in patients with chronic kidney disease.

N. Kanomata, H. Sugiyama, Y. Maeshima, 2014, Acta medica Okayama.

Development of a novel estimation method for hemoglobin A1c using glycated albumin in type 2 diabetes mellitus patients with end-stage renal disease

H. Makino, J. Wada, R. Kodera, 2018, Diabetology International.

Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model

H. Sugiyama, Y. Maeshima, Yasufumi Sato, 2018, PloS one.

ONO-1301, a sustained-release prostacyclin analog, ameliorates the renal alterations in a mouse type 2 diabetes model possibly through its protective effects on mesangial cells.

H. Sugiyama, Y. Maeshima, H. Makino, 2015, Acta medica Okayama.

Urinary and Plasma Levels of Vasohibin-1 Can Predict Renal Functional Deterioration in Patients with Renal Disorders

H. Sugiyama, Y. Maeshima, H. Makino, 2014, PloS one.

Sustained-release prostacyclin analog ONO-1301 ameliorates tubulointerstitial alterations in a mouse obstructive nephropathy model.

T. Sugaya, Kunio Matsumoto, H. Sugiyama, 2012, American journal of physiology. Renal physiology.

Exacerbation of Diabetic Renal Alterations in Mice Lacking Vasohibin-1

H. Sugiyama, Y. Maeshima, H. Makino, 2014, PloS one.

Vasohibin‐1 deficiency enhances renal fibrosis and inflammation after unilateral ureteral obstruction

F. Otsuka, H. Sugiyama, Y. Maeshima, 2014, Physiological reports.